Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Infliximab
Remicade
Routinely available
SMC (318/06)
01/11/2008
Indication
Severe plaque psoriasis
Therapeutic Area
Skin
Status Description
Routinely available in line with national guidance
Formulation
100mg powder for intravenous infusion
Comments
November 2008 - Added to the Additional List. June 2019 (as per LJF) - Routinely available in line with national guidance. Included in the Additional List, for Specialist Use only.